Passage Bio (PASG) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free PASG Stock Alerts $1.50 -0.08 (-5.06%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Passage Bio Short Interest DataCurrent Short Volume1,750,000 sharesPrevious Short Volume1,320,000 sharesChange Vs. Previous Month+32.58%Dollar Volume Sold Short$2.15 millionShort Interest Ratio / Days to Cover5.1Last Record DateApril 15, 2024Outstanding Shares61,610,000 sharesFloat Size41,240,000 sharesShort Percent of Float4.24%Today's Trading Volume187,112 sharesAverage Trading Volume332,447 sharesToday's Volume Vs. Average56% Short Selling Passage Bio ? Sign up to receive the latest short interest report for Passage Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPASG Short Interest Over TimePASG Days to Cover Over TimePASG Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Passage Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,750,000 shares $2.15 million +32.6%4.2%5.1 $1.23 3/31/20241,320,000 shares $1.78 million +9.1%3.6%3.4 $1.35 3/15/20241,210,000 shares $1.82 million +116.9%3.3%2.5 $1.50 2/29/2024557,800 shares $953,838.00 +122.0%1.5%0.9 $1.71 2/15/2024251,300 shares $331,716.00 -9.5%0.7%0.4 $1.32 1/31/2024277,700 shares $272,146.00 -12.2%0.8%0.4 $0.98 Get the Latest News and Ratings for PASG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Passage Bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024316,300 shares $341,604.00 -17.6%0.9%0.5 $1.08 12/31/2023383,700 shares $387,537.00 +56.5%1.1%0.6 $1.01 12/15/2023245,200 shares $184,096.16 +1.5%0.7%0.4 $0.75 11/30/2023241,500 shares $152,410.65 -8.0%0.7%1 $0.63 11/15/2023262,400 shares $164,656.00 +14.9%0.7%1.3 $0.63 10/31/2023228,300 shares $146,112.00 -3.9%0.7%1.2 $0.64 10/15/2023237,500 shares $156,750.00 -4.7%0.7%1.5 $0.66 9/30/2023249,200 shares $163,973.60 +18.4%0.7%1.4 $0.66 9/15/2023210,500 shares $156,927.75 +5.3%0.6%1 $0.75 8/31/2023199,900 shares $156,121.90 -2.6%0.6%0.7 $0.78 8/15/2023205,300 shares $164,855.90 +13.0%0.6%0.7 $0.80 7/31/2023181,700 shares $160,077.70 -23.9%0.5%0.7 $0.88 7/15/2023238,900 shares $240,094.50 +8.1%0.8%1 $1.01 6/30/2023221,100 shares $208,121.43 -26.4%0.7%0.9 $0.94 6/15/2023300,400 shares $284,779.20 +11.8%1.0%1.4 $0.95 5/31/2023268,600 shares $255,438.60 +3.3%0.9%1.8 $0.95 5/15/2023260,100 shares $267,903.00 -10.5%0.9%1.7 $1.03 4/30/2023290,600 shares $302,224.00 -9.7%1.0%1.8 $1.04 4/15/2023321,800 shares $344,326.00 -12.7%1.1%2 $1.07 3/31/2023368,600 shares $353,008.22 +12.6%1.3%2.4 $0.96 3/15/2023327,400 shares $353,592.00 -2.2%1.1%2.1 $1.08 2/28/2023334,800 shares $411,804.00 +11.2%1.2%1.7 $1.23 2/15/2023301,200 shares $394,572.00 +4.7%1.0%1.5 $1.31 1/31/2023287,800 shares $420,188.00 -15.5%1.0%1.3 $1.46 1/15/2023340,600 shares $558,584.00 -8.0%1.2%1.5 $1.64 12/30/2022370,100 shares $510,738.00 -5.8%1.3%1.6 $1.38 12/15/2022392,700 shares $479,094.00 +18.6%1.4%1.7 $1.22 11/30/2022331,000 shares $403,820.00 -6.0%1.2%1.3 $1.22 11/15/2022352,100 shares $517,587.00 -15.4%1.2%1.4 $1.47 10/31/2022416,000 shares $507,520.00 -27.1%1.5%1.6 $1.22 10/15/2022570,900 shares $679,371.00 -21.1%2.1%2.1 $1.19 9/30/2022723,700 shares $904,625.00 -3.4%2.6%2.7 $1.25 9/15/2022748,800 shares $1.22 million -19.6%2.7%2.2 $1.63 8/31/2022931,200 shares $1.88 million -5.7%3.4%2.6 $2.02The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. PASG Short Interest - Frequently Asked Questions What is Passage Bio's current short interest? Short interest is the volume of Passage Bio shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,750,000 shares of PASG short. 4.24% of Passage Bio's shares are currently sold short. Learn More on Passage Bio's current short interest. What is a good short interest ratio for Passage Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PASG shares currently have a short interest ratio of 5.0. Learn More on Passage Bio's short interest ratio. What is a good short interest percentage for Passage Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.24% of Passage Bio's floating shares are currently sold short. Is Passage Bio's short interest increasing or decreasing? Passage Bio saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,750,000 shares, an increase of 32.6% from the previous total of 1,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Passage Bio's float size? Passage Bio currently has issued a total of 61,610,000 shares. Some of Passage Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Passage Bio currently has a public float of 41,240,000 shares. How does Passage Bio's short interest compare to its competitors? 4.24% of Passage Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Passage Bio: Curis, Inc. (1.01%), AlloVir, Inc. (5.57%), Outlook Therapeutics, Inc. (7.41%), Gritstone bio, Inc. (13.16%), bluebird bio, Inc. (29.83%), Athira Pharma, Inc. (2.94%), Sangamo Therapeutics, Inc. (6.39%), aTyr Pharma, Inc. (0.56%), Cognition Therapeutics, Inc. (0.73%), Omega Therapeutics, Inc. (21.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Passage Bio stock? Short selling PASG is an investing strategy that aims to generate trading profit from Passage Bio as its price is falling. PASG shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Passage Bio? A short squeeze for Passage Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PASG, which in turn drives the price of the stock up even further. How often is Passage Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PASG, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRIS Short Interest Data ALVR Short Interest Data OTLK Short Interest Data GRTS Short Interest Data BLUE Short Interest Data ATHA Short Interest Data SGMO Short Interest Data LIFE Short Interest Data CGTX Short Interest Data OMGA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PASG) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing